Cargando…

A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements

INTRODUCTION: Alzheimer’s disease (AD) is a disease continuum from pathophysiologic, biomarker and clinical perspectives. With the advent of advanced technologies, diagnosing and managing patients is evolving. METHODS: A systematic literature review (SLR) of practice guidelines for mild cognitive im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tahami Monfared, Amir Abbas, Phan, N. T. Nhan, Pearson, Isobel, Mauskopf, Josephine, Cho, Min, Zhang, Quanwu, Hampel, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310649/ https://www.ncbi.nlm.nih.gov/pubmed/37261607 http://dx.doi.org/10.1007/s40120-023-00504-6

Ejemplares similares

Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Alzheimer’s Disease: Epidemiology and Clinical Progression
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

The Humanistic and Economic Burden of Alzheimer's Disease
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

The Potential Economic Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer’s Disease
por: Morin, Peter J., et al.
Publicado: (2023)

A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer’s Disease
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2023)

Factors Driving the Transition of Alzheimer’s Disease Patients to Institutional Long-term Care
por: Davila, Heather, et al.
Publicado: (2021)

Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors
por: Dranitsaris, George, et al.
Publicado: (2022)

Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists
por: Dranitsaris, George, et al.
Publicado: (2023)

Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System
por: Morin, Peter, et al.
Publicado: (2022)

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation
por: Igarashi, Ataru, et al.
Publicado: (2023)

Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
por: Quon, Peter L., et al.
Publicado: (2019)

Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System
por: Aguilar, Byron J., et al.
Publicado: (2023)

Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
por: Haberstroh, Julia, et al.
Publicado: (2010)

Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2019)

Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis
por: McElroy, Heather, et al.
Publicado: (2021)

Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis
por: McElroy, Heather, et al.
Publicado: (2021)

Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis: A Systematic Review of Published Models and Clinical Practice Guidelines
por: Mauskopf, Josephine, et al.
Publicado: (2014)

Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials
por: Tahami Monfared, Amir A., et al.
Publicado: (2020)

Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?
por: Hampel, Harald, et al.
Publicado: (2013)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective
por: Graham, Jonathan, et al.
Publicado: (2016)

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
por: Mauskopf, Josephine, et al.
Publicado: (2021)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Current Guidelines and Future Strategies for the Management of Cow’s Milk Allergy
por: Vandenplas, Yvan, et al.
Publicado: (2021)

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
por: Gibson, Eddie, et al.
Publicado: (2017)

Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review
por: Copley-Merriman, Catherine, et al.
Publicado: (2018)

Strategies for Reforestation under Uncertain Future Climates: Guidelines for Alberta, Canada
por: Gray, Laura K., et al.
Publicado: (2011)

Using multicriteria decision analysis during drug development to predict reimbursement decisions
por: Williams, Paul, et al.
Publicado: (2014)

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
por: Shi, Jiong, et al.
Publicado: (2020)

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends
por: Zhang, Haolin, et al.
Publicado: (2021)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

Advances in the Treatment Strategies in Hypertension: Present and Future
por: Verdecchia, Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3j7qpk6g2o3grp5r7cbrtnghg